Seyedeh Hoda Alavizadeh | Pharmaceutical Science | Best Researcher Award

Published on by Research Awards

Assist Prof Dr. Seyedeh Hoda Alavizadeh | Pharmaceutical Science | Best Researcher Award

Assistant professor at Pharmaceutical Nanotechnology Department, School of Pharmacy, Mashhad University of Medical Sciences, Iran.

Seyedeh Hoda Alavizadeh is an accomplished assistant professor in pharmaceutical nanotechnology at Mashhad University of Medical Sciences, Iran. Her research focuses on innovative drug delivery systems, particularly liposomal formulations for targeted cancer therapy and neurodegenerative diseases. She has a strong academic background with a Pharm.D. and Ph.D. from MUMS, along with numerous honors including fellowships, grants, and awards like being recognized in the top 1% worldwide for her research. Her leadership extends to organizing international conferences and serving as a CRS ambassador. Alavizadeh’s contributions to pharmaceutical sciences are marked by her extensive publication record and active role in international collaborations and editorial activities.

Professional Profiles:

Education 🎓

Seyedeh Hoda Alavizadeh completed her Ph.D. in Pharmaceutical Nanotechnology at the School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Her doctoral research focused on the formulation and characterization of temperature-sensitive nanoliposomal cisplatin targeted with anti-Her-2/neu affibody, investigating its antitumor effects with local hyperthermia in vitro and in vivo using mouse tumor models. Under the guidance of Prof. Mahmoud Reza Jaafari, her work contributed significantly to understanding drug delivery mechanisms in cancer treatment. Prior to her Ph.D., she obtained her Pharm. D. from the same institution, specializing in vaccine delivery against leishmaniasis, supervised by Prof. Ali Khamesipour, Prof. Mahmoud Reza Jaafari, and Dr. Ali Badiee. Her Pharm. D. thesis focused on evaluating immune responses in mice inoculated with L. major mixed with LPD nanoparticles containing CpG ODN, demonstrating her early commitment to innovative pharmaceutical research.

Professional Experience

Since completing her education, Seyedeh Hoda Alavizadeh has served as an Assistant Professor at the Pharmaceutical Nanotechnology Department, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Her interdisciplinary research is grounded in innovation and quality, focusing on developing tumor microenvironment-responsive liposomes for anti-cancer drug delivery. Her expertise includes the formulation of triggered-release liposomes—such as thermo, REDOX, and pH-sensitive formulations—tailored to the tumor microenvironment for cancer therapy and chemo-immunotherapy. She has been actively involved in teaching courses on pharmacy practice, basic biochemistry, biology, cell culture, and advanced topics in drug delivery using nanoparticles.

Research Interest

Seyedeh Hoda Alavizadeh’s research interests are centered on pharmaceutical nanotechnology, with a focus on developing advanced liposomal formulations for targeted drug delivery in cancer therapy. Her research explores triggered-release systems responsive to the tumor microenvironment, including thermo-sensitive, REDOX-sensitive, and pH-sensitive formulations. She is particularly interested in enhancing the efficacy of chemotherapy through innovative liposomal designs and investigating their applications in chemo-immunotherapy. Additionally, she is passionate about developing liposomal formulations of phytochemicals for their antioxidant and neuroprotective roles in diseases like Alzheimer’s and Parkinson’s, contributing to advancements in nanomedicine for therapeutic interventions.

Award and Honors

Seyedeh Hoda Alavizadeh has been recognized with several prestigious honors and awards throughout her career. She served as a CRS Ambassador from 2021 to 2023, promoting excellence in controlled release science. In 2020, she was awarded the Fellowship of the CLINAM Conference and Exhibition, held in Basel, Switzerland, highlighting her contributions to nanomedicine research. Her academic pursuits were further supported by the DAAD Scholarship for the ProGRANT proposal writing course in 2018 and the NIMAD research grant in the same year. Notably, she received the Best Poster Presentation Award at the CLINAM10th Conference and Exhibition in 2017 and was also honored with a Fellowship at the same event, recognizing her impactful research contributions. In 2016, her work was distinguished globally, ranking in the top 1% of papers by Essential Science Indicator of Thomson Reuters ISI, underscoring her significant scholarly impact.

Research Skills

Seyedeh Hoda Alavizadeh possesses a robust skill set in pharmaceutical nanotechnology, focusing on advanced drug delivery systems. Her expertise spans the development of liposomal formulations tailored for targeted delivery of chemotherapeutic agents and phytochemicals, leveraging innovative strategies such as thermo-responsive, REDOX-sensitive, and pH-sensitive mechanisms to optimize drug efficacy while minimizing adverse effects. With a comprehensive understanding of biochemical assays, she proficiently evaluates drug encapsulation efficiencies, release kinetics, and therapeutic outcomes in experimental models. Her academic leadership is evident through roles like vice-scientific chair for the ICNN2021 conference, underscoring her organizational acumen and commitment to advancing nanoscience and nanotechnology. Additionally, her active involvement in international collaborations and editorial responsibilities showcases her dedication to peer-reviewed research and scientific excellence in pharmaceutics and nanomedicine.

Publications

  • Bioactivity assessment and toxicity of crocin: a comprehensive review
    • Authors: SH Alavizadeh, H Hosseinzadeh
    • Year: 2014
    • Citations: 422
  • Novel nanomicelle formulation to enhance bioavailability and stability of curcuminoids
    • Authors: M Hatamipour, A Sahebkar, SH Alavizadeh, M Dorri, MR Jaafari
    • Year: 2019
    • Citations: 102
  • Antitumor activity of PEGylated nanoliposomes containing crocin in mice bearing C26 colon carcinoma
    • Authors: M Rastgoo, H Hosseinzadeh, H Alavizadeh, A Abbasi, Z Ayati, MR Jaafari
    • Year: 2013
    • Citations: 90
  • Redox-sensitive nanoscale drug delivery systems for cancer treatment
    • Authors: E Mirhadi, M Mashreghi, MF Maleki, SH Alavizadeh, L Arabi, A Badiee, …
    • Year: 2020
    • Citations: 80
  • Induction of protection against leishmaniasis in susceptible BALB/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA)
    • Authors: H Firouzmand, A Badiee, A Khamesipour, VH Shargh, SH Alavizadeh, …
    • Year: 2013
    • Citations: 63
  • Improved therapeutic activity of HER2 Affibody-targeted cisplatin liposomes in HER2-expressing breast tumor models
    • Authors: SH Alavizadeh, J Akhtari, A Badiee, S Golmohammadzadeh, MR Jaafari
    • Year: 2016
    • Citations: 56
  • Targeting, biodistribution and tumor growth inhibiting characterization of anti-HER2 affibody coupling to liposomal doxorubicin using BALB/c mice bearing TUBO tumors
    • Authors: J Akhtari, SM Rezayat, M Teymouri, SH Alavizadeh, F Gheybi, A Badiee, …
    • Year: 2016
    • Citations: 48
  • Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
    • Authors: MR Jaafari, M Hatamipour, SH Alavizadeh, A Abbasi, Z Saberi, S Rafati, …
    • Year: 2019
    • Citations: 46
  • The influence of phospholipid on the physicochemical properties and anti-tumor efficacy of liposomes encapsulating cisplatin in mice bearing C26 colon carcinoma
    • Authors: SH Alavizadeh, A Badiee, S Golmohammadzadeh, MR Jaafari
    • Year: 2014
    • Citations: 46
  • Development of topical liposomes containing miltefosine for the treatment of Leishmania major infection in susceptible BALB/c mice
    • Authors: Z Kavian, SH Alavizadeh, S Golmohamadzadeh, A Badiee, …
    • Year: 2019
    • Citations: 40
  • The molecular mechanisms of curcumin’s inhibitory effects on cancer stem cells
    • Authors: E Zendehdel, E Abdollahi, AA Momtazi‐Borojeni, M Korani, …
    • Year: 2019
    • Citations: 34

 

Guangqing Yu | Genetics and Molecular Biology | Best Researcher Award

Published on by Research Awards

Dr. Guangqing Yu | Genetics and Molecular Biology | Best Researcher Award

associate professor at Henan Agricultural University, China.

Guangqing Yu is highly skilled in genetics and molecular biology, utilizing zebrafish to explore immune and developmental responses. His expertise encompasses epigenetic analysis, molecular biology techniques (PCR, gene cloning, sequencing), and immunological assays. He is adept at studying embryonic development, analyzing complex biological data, and designing comprehensive experiments. With a strong proficiency in scientific writing, Guangqing has published extensively in high-impact journals. Additionally, he has significant experience in project management, including overseeing research projects, acquiring funding, and fostering collaborative efforts.

Professional Profiles:

Education 🎓

Guangqing Yu holds a Doctorate, majoring in genetics. His academic focus has been on utilizing zebrafish as a model to study the mechanisms of fish immune and developmental responses, particularly investigating the function and molecular mechanisms of epigenetic modifications in fish innate immunity against viruses and embryonic development.

Professional Experience

Guangqing Yu is an associate professor at Henan Agricultural University. His research primarily focuses on genetics, utilizing zebrafish as a model to explore mechanisms of fish immune and developmental responses. He has investigated the functions and molecular mechanisms of epigenetic modifications in fish innate immunity against viruses and in embryonic development. His research findings have been published in prestigious journals such as Development, Journal of Immunology, Frontiers in Immunology, BMC Genomics, and Journal of Biological Chemistry. Additionally, Guangqing Yu has participated in the Major Research Program of the National Natural Science Foundation of China, contributing to the understanding of the molecular genetic basis of hypoxic adaptive evolution in Cyprinid fish.

Research Interest

Guangqing Yu’s research interests are centered on the fields of biochemistry, genetics, and molecular biology. He focuses on using zebrafish as a model organism to study the mechanisms of fish immune and developmental responses. His investigations delve into the function and molecular mechanisms of epigenetic modifications in fish innate immunity against viruses and embryonic development. Guangqing is particularly interested in understanding how epigenetic changes influence immune responses and developmental processes, contributing to a broader comprehension of genetic and molecular pathways in aquatic organisms.

Award and Honors

Guangqing Yu has received recognition for his significant contributions to the field of genetics and molecular biology. His work on the mechanisms of fish immune and developmental responses, particularly the function and molecular mechanisms of epigenetic modifications, has garnered accolades in academic circles. He has been honored for his research excellence with multiple awards, reflecting his commitment to advancing scientific understanding and his impactful contributions to the study of innate immunity and embryonic development in aquatic organisms.

Research Skills

Guangqing Yu possesses a robust set of research skills, particularly in the fields of genetics and molecular biology. He is adept at using zebrafish as a model organism to investigate immune and developmental responses. His expertise includes epigenetic analysis, where he studies the function and molecular mechanisms of epigenetic modifications in fish. Guangqing is skilled in various molecular biology techniques, including PCR, gene cloning, and sequencing. He is also experienced in conducting immunological assays to study innate immunity against viruses and has significant expertise in examining embryonic development and the genetic factors influencing these processes. Competent in analyzing and interpreting complex biological data using bioinformatics tools, Guangqing excels in research design, capable of conducting comprehensive experiments to test hypotheses related to fish immune responses and development. He is proficient in scientific writing, with numerous publications in high-impact journals such as Development, Journal of Immunology, and BMC Genomics. Additionally, Guangqing has substantial experience in project management, overseeing and supervising research projects, including funding acquisition and collaborative efforts.

Publications

  1. Exploring the effects of vasoactive constituents in large cardamom: implications for the anti-hypertensive effect via eNOS coupling pathway–an in-vitro study in rat endothelial cells
    • Authors: Mandal, P., Pradhan, S.M., Mathew, A.A., Unni, A.R., Kanthlal, S.K.
    • Year: 2024
  2. Vascular targeting of constituents of commonly used spices and its molecular interactions in endothelial dysfunction: A review
    • Authors: Mandal, P., Kanthlal, S.K.
    • Year: 2024
  3. Inhibiting Monoamine Oxidase in CNS and CVS would be a Promising Approach to Mitigating Cardiovascular Complications in Neurodegenerative Disorders
    • Authors: Srivastava, P., Sudevan, S.T., Thennavan, A., Mathew, B., Kanthlal, S.K.
    • Year: 2024
    • Citations: 1
  4. Novel 1-H Phenyl Benzimidazole Derivatives for IBD Therapy-An in-vitro and in-silico Approach to Evaluate its Effects on the IL-23 Mediated Inflammatory Pathway
    • Authors: Vishnu, V., Krishnendu, P.R., Zachariah, S.M., Kanthlal, S.K.
    • Year: 2024
  5. Apoptosis promoting activity of selected plant steroid in MRMT-1 breast cancer cell line by modulating mitochondrial permeation pathway
    • Authors: Aslam, M., Augustine, S., Ann Mathew, A., Kanthlal, S.K., Panonummal, R.
    • Year: 2023
    • Citations: 1
  6. Targeting viral ORF3a protein: A new approach to mitigate COVID-19 induced Immune cell apoptosis and associated respiratory complications
    • Authors: Treeza, M.M., Augustine, S., Mathew, A.A., Kanthlal, S.K., Panonummal, R.
    • Year: 2023
    • Citations: 1
  7. Large Cardamom Extract Enhances Ramipril’s Vasoprotective Action by Modulating Endothelial Redox Biology. An Evaluation based on in-silico and in-vitro Research
    • Authors: Amritha, A.M., Shakhi Shylesh, C.M., Nair, K.R., Uma Devi, P., Kanthlal, S.K.
    • Year: 2022
  8. The Role of Mitochondrial Genes in Neurodegenerative Disorders
    • Authors: Kumar, R., Harilal, S., Parambi, D.G.T., Batiha, G.E.-S., Mathew, B.
    • Year: 2022
    • Citations: 5
  9. Effect of Hydroaloholic Extract of Rotula Aquatica Lour on Gentamicin-Induced Nephrotoxicity in Wistar Albino Rats: An In Vitro and In Vivo Approach
    • Authors: Narayanan, S.E., Abdelgawad, M.A., Althobaiti, Y.S., Kanthlal, S.K., Mathew, B.
    • Year: 2022
  10. Spices and Hypertension: An Insight for Researchers
    • Authors: Nair, K.R., Arya, V.S., Kanthlal, S.K., Uma, D.P.
    • Year: 2022

 

 

 

Pritisha Sarkar | Computer Science | Young Scientist Award

Published on by Research Awards

Ms. Pritisha Sarkar | Computer Science | Young Scientist Award

Research scholar at NIT Durgapur, India.

Ms. Pritisha Sarkar is a dedicated researcher specializing in machine learning and deep learning within the realm of computer science. Her expertise spans conducting thorough literature reviews, designing and implementing experiments, and analyzing data using statistical methods and programming languages like Python, R, and Java. She applies advanced algorithms to solve complex problems in areas such as natural language processing and computer vision. Collaborative and innovative, Pritisha excels in interdisciplinary environments, contributing effectively to research teams. She communicates her findings effectively through scholarly publications and presentations, demonstrating a commitment to advancing knowledge and technology in her field.

Professional Profiles:

Education

Ms. Pritisha Sarkar is currently pursuing her Ph.D. in Computer Science at NIT Durgapur, focusing on machine learning and deep learning. She completed her B.Tech in Information Technology from the Government College of Engineering and Leather Technology under M.A.K.A.U.T, Kolkata, graduating in 2016 with a DGPA of 7.84. Continuing her academic journey, she pursued an M.Tech in Computer Science at the National Institute of Technical Teachers’ Training & Research, Kolkata, graduating in 2018 with a DGPA of 8.15. Pritisha’s educational background highlights her dedication to advancing her expertise in computer science, particularly in machine learning and deep learning.

Research Interest

Ms. Pritisha Sarkar’s research interests encompass machine learning and deep learning, particularly focusing on advanced algorithms, neural networks, and their applications in areas such as natural language processing, computer vision, and data analytics. Her academic pursuits and ongoing Ph.D. research at NIT Durgapur underscore her commitment to exploring these technologies and their practical implementations.

Research Skills

Ms. Pritisha Sarkar excels in a wide array of research skills cultivated throughout her academic and professional journey. Her expertise includes conducting comprehensive literature reviews to discern existing research trends and identify areas for exploration. She is adept at designing and executing experiments to validate hypotheses and advance scientific knowledge. Proficient in data analysis using statistical methods and programming languages like Python, R, and Java, she applies these skills to extract meaningful insights from complex datasets. Specializing in machine learning and deep learning, Pritisha employs advanced algorithms to address intricate challenges in domains such as natural language processing and computer vision. Her problem-solving abilities and analytical mindset enable her to innovate and develop impactful solutions. Collaborative by nature, she thrives in interdisciplinary environments, contributing effectively to research teams. Pritisha communicates her findings with clarity and precision through scholarly papers, presentations, and discussions, ensuring her research makes a significant impact in the field of computer science.

Publications

  • Optimizing air quality monitoring device deployment: a strategy to enhance distribution efficiency
    • Authors: P. Sarkar, M. Saha
    • Journal: International Journal of Information Technology (Singapore)
    • Year: 2024
    • Volume: 16
    • Issue: 5
    • Pages: 2981–2985
  • Machine learning-based detection of sudden air pollutant level changes: impacts on public health
    • Authors: P. Sarkar, M. Saha
    • Journal: International Journal of Information Technology (Singapore)
    • Year: 2024
    • Article in Press
  • Impact of bursting fireworks during Diwali in Durgapur suburb, India: A case study
    • Authors: P. Sarkar, M.K. Makkena, A. Bose, S. Saha, M. Saha
    • Conference: ACM International Conference Proceeding Series
    • Year: 2023
    • Pages: 384–389
    • Citations: 2
  • Analyzing the Severity of Air Pollution in an Industrialized Suburb
    • Authors: P. Sarkar, M.K. Makkena, S. Saha, M. Saha
    • Conference: 14th International Conference on Computing Communication and Networking Technologies (ICCCNT 2023)
    • Year: 2023
  • City-wide Spatio-temporal Effect on AQI
    • Authors: P. Sarkar, S. Ahmed, A. Bose, S. Saha, M. Saha
    • Conference: Proceedings of 4th International Conference on Cybernetics, Cognition and Machine Learning Applications (ICCCMLA 2022)
    • Year: 2022
    • Pages: 13–18
    • Citations: 2
  • Nature-Inspired Computing Behaviour of Cellular Automata
    • Authors: M. Ghosh, P. Sarkar, M. Saha
    • Book: Lecture Notes in Electrical Engineering
    • Year: 2021
    • Volume: 694
    • Pages: 137–149
    • Citations: 1
  • An Intelligent Technique to Find Bicliques and its Application to Optimum Matching Problem
    • Authors: P. Sarkar, K. Giri
    • Conference: International Conference on Emerging Trends in Information Technology and Engineering (ic-ETITE 2020)
    • Year: 2020
    • Article ID: 9077790
    • Citations: 1

 

Amedeo De Nicolò | Pharmaceutical Science | Best Researcher Award

Published on by Research Awards

Dr. Amedeo De Nicolò | Pharmaceutical Science | Best Researcher Award

Ricercatore a Tempo Determinato Cat. B at University of Turin, Italy.

Amedeo De Nicolò, born on April 20, 1987, is an Italian researcher currently affiliated with the University of Turin. He holds a PhD in Medicine and Experimental Therapy and a Master’s degree in Cellular and Molecular Biology. De Nicolò specializes in pharmacology, focusing on pharmacokinetics and pharmacogenetics. His research interests include developing bioanalytical methods for Therapeutic Drug Monitoring (TDM) and studying drug interactions and pharmacokinetic/pharmacodynamic evaluations. Throughout his career, he has contributed significantly to clinical pharmacology through various research projects, publications, and participation in international collaborations. In addition to his research, De Nicolò has a strong teaching background, having taught pharmacology courses at the University of Turin and participated in a Master’s program related to biological product control in the industry. He is also an active member of several scientific societies and working groups, including the Italian Society of Pharmacology and the international research consortium VirTUAL.

Professional Profiles:

Education

Amedeo De Nicolò completed his PhD in Medicine and Experimental Therapy from the University of Turin in January 2017. His dissertation focused on the “Pharmacokinetics and Pharmacogenetics of Anti-HCV Treatments,” receiving positive evaluations. Prior to his doctorate, he earned a Master’s degree in Cellular and Molecular Biology, with a Biomedical curriculum, from the same university in October 2011. His master’s thesis titled “Identificazione di Nuovi Parametri Farmacocinetici per la Valutazione Precoce del Rischio di Anemizzazione in Pazienti Sottoposti a Terapia Anti-HCV Standard” was awarded the highest honors, graduating with a score of 110/110 cum laude. Additionally, he holds a Bachelor’s degree in Biological Sciences from the University of Turin, obtained in December 2009. Throughout his academic journey, De Nicolò acquired substantial competencies in biological sciences, clinical pharmacology, laboratory medicine, and statistics. In August 2020, he also achieved professional licensure as a Biologist, further solidifying his qualifications in the field.

Professional Experience

Amedeo De Nicolò is currently a fixed-term researcher (type B) at the University of Turin, specializing in pharmacokinetics and pharmacogenetics. He has been involved in clinical pharmacology research since his internship for his master’s thesis in 2010-2011. From March 2022, he has held his current position at the Department of Medical Sciences, focusing on the development, validation, and application of bioanalytical methods in liquid chromatography for Therapeutic Drug Monitoring (TDM). Prior to this, he was a research fellow from July 2017 to February 2022 at the same institution. During this period, he contributed significantly to pharmacokinetic studies, particularly related to drug-drug interactions and the pharmacokinetic/pharmacodynamic evaluations of antiviral and tuberculosis treatments under the international DERIVE project. De Nicolò has also provided clinical consultancy in interpreting TDM results and has actively participated in the ISO certification processes for biomedical diagnostic kit validations. His extensive experience includes conducting routine drug analysis and providing clinical pharmacological advice since 2012. In addition to his research, he has taught pharmacology modules at the University of Turin for various nursing programs and a master’s course, contributing to academic education alongside his research duties.

Research Interest

Amedeo De Nicolò’s research interests lie primarily in the fields of pharmacokinetics and pharmacogenetics, focusing on clinical pharmacology. His work involves the development, validation, and application of bioanalytical methods using liquid chromatography for Therapeutic Drug Monitoring (TDM). He is particularly interested in studying drug-drug interactions, evaluating pharmacokinetic and pharmacodynamic relationships, and interpreting clinical data through statistical analysis. De Nicolò is also engaged in research related to the pharmacokinetics of antiviral treatments and the intracellular measurement of anti-infective drugs. His involvement in international research consortia, such as VirTUAL and the COVID-19 Mass Spectrometry Coalition, highlights his commitment to advancing knowledge in these areas. Additionally, De Nicolò’s research extends to the standardization of methodological approaches in TDM, contributing to the enhancement of clinical practices and patient care.

Award and Honors

Amedeo De Nicolò has received several notable awards and honors throughout his career, reflecting his significant contributions to the field of clinical pharmacology. He obtained the National Scientific Qualification as Associate Professor in the sector of Pharmacology, Clinical Pharmacology, and Pharmacognosy (05/G1) on November 6, 2018. This achievement recognizes his expertise and leadership in pharmacological research. Furthermore, De Nicolò became a licensed Biologist on August 12, 2020, showcasing his professional qualifications in biological sciences. His work is also distinguished by his active membership in prominent scientific societies, such as the Italian Society of Pharmacology (SIF) and the Italian Society of Clinical Biochemistry (SIBioC), where he continues to contribute to the advancement of pharmacological sciences.

Research skills

Amedeo De Nicolò possesses a robust set of research skills honed through extensive experience in clinical pharmacology. His expertise includes the development, validation, and application of bioanalytical methods in liquid chromatography for Therapeutic Drug Monitoring (TDM), adhering to ISO 9001 and ISO 13485 standards. He excels in pharmacokinetics and pharmacogenetics, focusing on drug interactions, efficacy, and toxicity. De Nicolò is proficient in statistical analysis and the interpretation of clinical and pharmacogenetic data. Additionally, he has a strong background in conducting and coordinating pharmacokinetic studies, including those involving intracellular drug measurements and therapeutic drug monitoring in various medical contexts. His skills are complemented by his ability to write and publish scientific articles, contributing significantly to the body of knowledge in clinical pharmacology.

Publications

  1. Pharmacogenetics of tenofovir drug transporters in the context of HBV: Is there an impact?
    • Authors: Cusato, J., Manca, A., Palermiti, A., Boglione, L., D’Avolio, A.
    • Year: 2024
    • Citations: 0
  2. Cannabinoid levels description in a cohort of patients with chronic and neuropathic pain treated with Cannabis decoction: A possible role of TDM
    • Authors: Manca, A., Valz, C., Chiara, F., Cusato, J., D’Avolio, A.
    • Year: 2024
    • Citations: 0
  3. Pharmacokinetics and Safety of Twice-daily Ritonavir-boosted Atazanavir with Rifampicin
    • Authors: Gausi, K., Mugerwa, H., Siccardi, M., Denti, P., Waitt, C.
    • Year: 2024
    • Citations: 1
  4. Comparative Performance Assessment of Novel Fluorescence Immunoassay POCTs for Measuring Circulating Levels of Vitamin-D
    • Authors: Palermiti, A., Manca, A., Mastrantonio, F., De Nicolò, A., D’Avolio, A.
    • Year: 2024
    • Citations: 0
  5. Pharmacokinetics of tecovirimat in subjects with Mpox
    • Authors: Tempestilli, M., Mondi, A., D’Avolio, A., Vaia, F., Antinori, A.
    • Year: 2024
    • Citations: 0
  6. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate in a cohort of patients with HBV infection: A retrospective study
    • Authors: Stroffolini, G., Dodaro, V., De Nicolò, A., D’Avolio, A., Boglione, L.
    • Year: 2024
    • Citations: 0
  7. Pharmacokinetics and pharmacogenetics of high-dosage tedizolid for disseminated nocardiosis in a lung transplant patient
    • Authors: Corcione, S., Vita, D., De Nicolò, A., D’Avolio, A., De Rosa, F.G.
    • Year: 2023
    • Citations: 0
  8. Experimental pharmacology in precision medicine
    • Authors: Urbaniak, A., Thummel, K.E., Alade, A.N., Sheppard, D.N., Jarvis, M.F.
    • Year: 2023
    • Citations: 1
  9. Stability Study of Fosfomycin in Elastomeric Pumps at 4 °C and 34 °C: Technical Bases for a Continuous Infusion Use for Outpatient Parenteral Antibiotic Therapy
    • Authors: Manca, A., Palermiti, A., Mula, J., De Nicolò, A., D’Avolio, A.
    • Year: 2023
    • Citations: 0
  10. Vitamin D impact in affecting clozapine plasma exposure: A potential contribution of seasonality
    • Authors: Manca, A., Mula, J., Palermiti, A., Cusato, J., D’Avolio, A.
    • Year: 2023
    • Citations: 0